Juanjo Cragnolini
Associate Director, Oncology Search & Evaluation Takeda
Juanjo Cragnolini, PhD, is an Oncology Search & Evaluation Lead at Takeda, where he focuses on identifying and advancing external innovation opportunities to strengthen the company’s oncology pipeline. Prior to joining Takeda, Juanjo held roles at GSK across Oncology R&D and Biopharma Discovery, including Associate Director within Partnerships & External Innovation. Juanjo’s background combines deep scientific expertise with business development acumen, with experience spanning CAR-T cell therapy, immuno-oncology, and biologics discovery. He trained at the Massachusetts Institute of Technology.
Seminars
Wednesday 9th September 2026
Pharma Icebreaker Tables: Accelerating Connections
8:30 am
- The pharma icebreaker tables running in each track create introductions between biotech and pharma
- Two weeks out from the conference, pharma will review attending biotech and biotech will review attending pharma, with both making selection to meet with companies they haven’t scheduled meetings with yet through the One-to-One Partnering Portal
- With these selections, we will build a schedule of company rotations through each pharma’s table
- Join three tables, led by three pharma, for 30 minutes each. Mixed groups rather than 1-2-1s, hear how your peers pitch themselves whilst also getting facetime with pharma yourself, first thing on day one
Wednesday 9th September 2026
Pharma Icebreaker Panel Discussion
7:45 am
- Understanding what it takes for pharma to invest. What are the current budgetary considerations within pharma?
- How is pharma assessing novel technologies, and where do they place within portfolios?
- What feels differentiated in a crowded space? From pharma’s perspective, what will make something best-in-class?
